跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 160 条关于
“GPR3”
全部
160
临床试验
65
药物
84
机构
0
资讯
11
3个月前
GPCR Dimers and Heteromers: Emerging Therapeutic Paradigms in Neuropsychiatric Disorders
去年
ThirtyFiveBio Secures Bridge Financing to Advance Novel GPR35 Inhibitor for Ulcerative Colitis Treatment
去年
Gene Therapy and GPR6 Inverse Agonist Show Promise in Parkinson's Disease Trials
去年
Armored anti-GPC3 JW-004 shows increased potency against HCC | BioWorld
去年
Anti-GPC3 Targeted Therapies Market Expands with Novel Treatment Approaches for Hepatocellular Carcinoma
14天前
Acepodia's GPC3-Targeted Dual-Payload ADC ACE723 Clears FDA IND for Hepatocellular Carcinoma
去年
NAYA Biosciences Initiates Phase 1/2a Trial of NY-303 for Hepatocellular Carcinoma
去年
NAYA Biosciences Initiates Phase 1/2a Trial of NY-303 for Hepatocellular Carcinoma
8个月前
Oricell Therapeutics Raises $70M Series C1 to Advance GPC3-Targeted CAR-T Therapy for Hepatocellular Carcinoma
去年
CARsgen Secures European Patent Protection for GPC3-Targeted CAR-T Therapy Following Successful Defense at EPO
第 1 页,共 2 页
上一页
下一页